AGEIST Unlocking the Secrets of Lifespan Extension with Karl Pfleger
This week, we speak with Karl Pfleger, PhD who, after studying Machine Learning at Stanford and working a successful tech career, now does all he can to support longevity research and biotech. Karl discusses the inadequacies of traditional healthcare in addressing the root causes of aging and shares insights on groundbreaking research that can slow down or even reverse aging processes. He emphasizes the significant impact of lifestyle choices on longevity and previews promising future therapies, including stem cell treatments and mitochondrial health interventions.
What kind of SuperAger are you? Check the SuperAge Quiz and find out! (visit: ageist.com/quiz)
Thanks to our sponsors:
InsideTracker – the dashboard to your Inner Health. Listeners get 20% off on all products at InsideTracker.com/AGEIST.
Timeline Nutrition — our favorite supplement for cell support and mitochondrial function. Listeners receive 10% off your first order of Mitopure with code AGEIST at TimelineNutrition.com/ageist.
AmeriCorps Seniors — Get involved in your community through AmeriCorps Seniors’ volunteer opportunities and change your life. Go to AmeriCorps.gov/YourMoment
Key Moments
“So the traditional health care and medical practice in our country, in the US and most of the world concerns really considering everyone to be baseline healthy until they get sick to a level where they're very sick and they cross some kind of a threshold for diagnosis of having an actual disease. So even though we call it health care, a lot of people kind of pejoratively describe it as sick care.”
“In short-lived species you can extend lifespans manyfold. One single gene mutation in worms can extend their lifespans by 10X, for example. And even in mice, we have interventions now that can extend their lifespans by 30% or 40% sometimes. And many of these interventions work across multiple species. So we believe they’re likely to work for people as well."
“I wanted them to realize how big [the longevity field] had gotten so that they wouldn't delay getting into it with more serious amounts of money. They didn't realize that they were two years behind given how fast it was growing.”
Connect with Karl Pfleger
X
AgingBiotech.info
LinkedIn